Idera Pharmaceuticals - 25 Year Stock Price History | IDRA

Historical daily share price chart and data for Idera Pharmaceuticals since 1996 adjusted for splits. The latest closing stock price for Idera Pharmaceuticals as of September 24, 2021 is 1.11.
  • The all-time high Idera Pharmaceuticals stock closing price was 4361.60 on January 31, 1996.
  • The Idera Pharmaceuticals 52-week high stock price is 6.14, which is 453.2% above the current share price.
  • The Idera Pharmaceuticals 52-week low stock price is 0.97, which is 12.6% below the current share price.
  • The average Idera Pharmaceuticals stock price for the last 52 weeks is 2.51.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Idera Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 2.2148 4.0200 5.9800 1.0000 1.1100 -69.75%
2020 2.2275 1.8450 5.1800 1.0600 3.6700 101.65%
2019 2.5992 3.5200 3.9700 1.4500 1.8200 -34.30%
2018 11.2375 17.6800 20.4000 2.7700 2.7700 -83.59%
2017 15.4553 12.0000 22.1600 10.8000 16.8800 40.67%
2016 14.5724 24.0000 24.0000 10.5600 12.0000 -51.46%
2015 28.7479 39.2000 42.9600 19.4400 24.7200 -29.93%
2014 27.2010 38.0000 52.7200 15.6800 35.2800 -4.75%
2013 10.6488 6.3600 37.0400 3.6800 37.0400 420.22%
2012 8.8515 9.2800 16.6400 5.4400 7.1200 -15.24%
2011 16.4085 23.1200 26.0000 7.7600 8.4000 -63.67%
2010 32.4973 42.1600 55.5200 18.8800 23.1200 -44.10%
2009 51.2517 64.2400 72.4800 37.2000 41.3600 -32.68%
2008 95.8834 106.2400 123.2800 47.2800 61.4400 -41.37%
2007 70.9406 42.2400 104.8000 42.2400 104.8000 143.04%
2006 33.8390 38.4000 45.9200 18.8800 43.1200 10.45%
2005 38.7759 32.0000 51.8400 29.4400 39.0400 27.08%
2004 46.5600 72.3200 83.8400 26.2400 30.7200 -57.89%
2003 61.0438 46.0800 108.1600 44.8000 72.9600 62.86%
2002 73.6508 105.6000 113.2800 38.4000 44.8000 -51.72%
2001 61.4839 32.0000 124.8000 31.3600 92.8000 245.24%
2000 97.0819 64.0000 416.0000 26.8800 26.8800 -58.82%
1999 59.1511 80.0000 120.3200 16.0000 65.2800 -37.04%
1998 137.5975 208.0000 216.3200 71.6800 103.6800 -46.00%
1997 1360.5489 1920.0000 2400.0000 167.6800 192.0000 -89.80%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.058B $0.001B
Idera Pharmaceuticals, Inc. is a drug discovery and development company that is developing drug candidates to treat cancer and infectious, respiratory, and autoimmune diseases, and for use in combination with therapeutic and prophylactic vaccines. Idera's proprietary drug candidates are designed to modulate Toll-like Receptors, the body's first line of immune defense. Idera's pioneering DNA chemistry expertise enables it to identify drug candidates for internal development and creates opportunities for multiple collaborative alliances.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71